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ABSTRACT  MDW4,  a  wheat  germ  agglutinin-resistant  nonmetastatic  mutant  of  the  highly 
metastatic  murine tumor cell  line called  MDAY-D2  has previously  been shown to attach  to 
fibronectin  and  type  IV collagen,  whereas MDAY-D2  and  phenotypic  revertants  of MDW4 
attached poorly to these substrates.  The increased  adhesiveness  of the mutant cells appeared 
to be closely related to a lesion  in cell surface  carbohydrate structures. In an effort to identify 
the carbohydrates involved  in cell attachment, glycopeptides  isolated  from mutant and wild- 
type cells  as well as from  purified  glycoproteins  were tested  for their ability  to  inhibit  the 
attachment  of MDW4  cells  to  plastic  surfaces  coated  with  fibronectin,  laminin,  or type  IV 
collagen. The addition of mannose-terminating glycopeptide to the adhesion assay inhibited 
MDW4 cell attachment to type IV collagen. In contrast, a sialylated  poly N-acetyllactosamine- 
containing  glycopeptide,  isolated  from  wheat germ  agglutinin-sensitive  MDAY-D2  cells  but 
absent in  MDW4 cells,  inhibited  MDW4 attachment to laminin.  None of the glycopeptides 
used in this study inhibited  attachment of MDW4 cells to fibronectin-coated  plastic.  Peptide 
N-glycosidase  treatment  of the  cells  to  remove  surface  asparagine-linked  oligosaccharides 
inhibited MDW4 adhesion to type IV collagen, but not to laminin, and the same treatment of 
the wheat germ agglutinin-sensitive  cells enhanced attachment to laminin. Tumor cell attach- 
ment to, and detachment  from,  the sublaminal  matrix  protein  laminin  and type  IV collagen 
are thought to be important events  in the metastatic process.  Our results  indicate that tumor 
cell  attachment to these  proteins  may be partially  modulated  by the  expression  of specific 
oligosaccharide structures associated  with the cell surface. 
Cell adhesion to extracellular matrix (ECM) 1 is necessary for 
most nonlymphoid cells to proliferate and differentiate (1, 2). 
Many of the  isolated structural  components of ECM  have 
been shown to mediate cell attachment in vitro,  and these 
include collagen types I-V, fibronectin, laminin, chondronec- 
tin,  entactin,  and  proteoglycans  (1).  The  composition  of 
ECMs depends on the type of cell producing the matrix. For 
example, fibroblasts synthesize and  preferentially attach  to 
fibronectin and types I and III collagen; the endothelial cell 
ECM that lines blood vessel walls contains laminin and type 
IV collagen  (1).  The  large  number  of adhesion-mediating 
components in  ECM,  and  the  fact that  some components 
J  Abbreviations  used in this paper: Ash, asparagine; Con A, concana- 
valin A;  ECM, extracellular matrix;  Gal,  galactose; GlcNAc, N- 
acetylglucosamine; IMDM, Iscove's modified Dulbecco's medium; 
Man, mannose;  WGA  r,  wheat  germ  agglutinin-resistant; WGA  s, 
wheat germ agglutinin-sensitive. 
have multiple binding sites has complicated the analysis of 
cell-substratum adhesion (1, 3). For example, fibronectin has 
binding sites for collagen,  fibrin,  heparin,  polyamines, and 
the cell surface. Laminin binds to type IV collagen, heparin 
sulfate,  and  a  cell  surface  receptor.  To  date  the  only  cell 
surface receptor for attachment to vascular ECM to be isolated 
is that of laminin (4, 5). The laminin receptor may be partic- 
ularly  important  to  the  metastatic phenotype  because  the 
ability  of tumor  cells  to  attach  to  laminin  plus  type  IV 
collagen-coated surfaces in vitro has been shown to correlate 
with the lung-colonizing potential of the cells when they are 
administered intravenously (6). 
Before attachment to  ECM  and invasion at a  secondary 
site, the metastatic tumor cell escapes from the primary site 
and passes through the vascular ECM to enter the circulation. 
This process may be facilitated by the decrease in tumor cell 
adhesiveness to ECM proteins that often accompanies malig- 
nant transformation. Malignant cells often have reduced cy- 
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explain  their  less  adhesive  properties (7).  It  has  also  been 
suggested that the commonly observed increase in sialylation 
and size of the asparagine (Asn)-linked oligosaccharides on 
malignant cells may play a role in tumor cell non-adhesiveness 
and consequently metastasis (8, 9). Recent studies on a num- 
ber of mutant cell lines have provided evidence that changes 
in  cell  surface carbohydrates can  affect cell  attachment to 
isolated ECM proteins. Ricin-resistant baby hamster kidney 
cells (I0) and wheat germ agglutinin-resistant (WGA  r) murine 
tumor cells (8) having lesions in the carbohydrate structure 
of their glycoconjugates also showed changes in adhesion to 
fibronectin and collagens. AD-6, a mutant of 3T3 fibroblasts 
which was selected  for increased detachability  from plastic 
surfaces, was subsequently found to have a defect in oligosac- 
charide biosynthesis (l 1).  Adhesion of melanoma cells (12) 
and fibroblasts (13) to fibronectin-coated plastic is reduced by 
treating the cells with tunicamycin, an inhibitor of Asn-linked 
oligosaccharide synthesis. 
There are a number of ways in which altered oligosaccha- 
ride structure may affect the normal function ofglycoproteins 
involved in cell attachment. For example, inhibition of Asn- 
linked  oligosaccharide  synthesis  by  tunicamycin  has  been 
shown to reduce the activity of the insulin receptor (14), alter 
the conformation and inhibit cell surface expression of the G 
protein in vesicular stomatitis virus-infected cells (15), and to 
inhibit Fc-related functions of IgG2b monoclonal antibodies 
without changing the hapten specific binding activity (16). In 
addition, the oligosaccharide portion of the glycoprotein can 
mediate a biological function by binding to a lectinlike recep- 
tor, an example of this being the delivery of lysosomal en- 
zymes to lysomes via the mannose-6-P binding protein in the 
endoplasmic reticulum of mammalian cells (17). 
Attachment of cells by membrane oligosaccharides to sur- 
faces  coated  with  lectins  (18)  glycosyltransferases (19)  and 
glycosidases  (18)  has been  shown to  induce  cell  spreading 
similar to cells plated on ECM- or fibronectin-coated surfaces. 
Therefore, we have examined the possibility that some ECM 
molecules have  lectinlike  activities  capable  of binding  cell 
surface oligosaccharides, thereby mediating attachment. Asn- 
linked  glycopeptides  have  been  isolated  from  MDW4,  a 
WGA r mutant and from the metastatic parental tumor line 
MDA-D2  (20).  The WGA r mutant attached more avidly to 
fibronectin- and type IV collagen-coated surfaces (8) and was 
shown to have a premature truncation of the antennae on the 
poly-N-acetyllactosamine-containing oligosaccharides  found 
in the wild-type cells (20).  Glycopeptides  from mutant and 
wild-type cells as well  as from standard glycoproteins were 
used  in  an  attempt  to  inhibit  MDW4  cell  attachment  to 
laminin, fibronectin, and type IV collagen, the major glyco- 
protein components of vascular ECM encountered by meta- 
static tumor cells. The results indicate that type IV collagen 
may bind to high mannose (Man) strucures on the cell surface, 
and  that  a  poly-N-acetyllactosamine-containing Asn-linked 
oligosaccharide found on the metastatic wheat germ agglu- 
tinin-sensitive (WGA s) cells inhibits cell attachment to lami- 
nin. Tumor cell detachment from vascular ECM at the pri- 
mary tumor sites and subsequent attachment to a structurally 
similar ECM at secondary sites may be facilitated by modu- 
lation of specific cell surface oligosaccharide structures. 
MATERIALS  AND  METHODS 
Materials:  Type IV collagen and laminin were purified from the murine 
EHS sarcoma and kindly provided by R. Timpl (Max-Planck-Institut  ffir Bio- 
chemie, Miinchen,  Federal Republic of Germany) (21, 22), Serum fibronectin 
was  purchased  from  Bethesda  Research  Laboratories  (Gaithersburg,  MD). 
Human transferrin,  conalbumin type I, essentially fatty acid-free, fraction  V 
BSA, and almond emulsin  /~-glucosidase type  II were obtained  from Sigma 
Chemical  Co.  (St. Louis,  MO).  Bio-Gel P-2  and  P-6  came from Bio-Rad 
Laboratories (Mississauga, Ontario,  Canada);  DE52 cellulose from Whatman 
Chemical Separation, Inc. (Clifton, NJ); concanavalin A-Sepharose-4B, DEAE 
Sephacel and Sepbadex G25 from Pharmacia Fine Chemicals (Dorval, Quebec, 
Canada);  and Reacti Gel (25DF)  from Pierce Chemical  Co. (Rockford,  IL). 
Terasaki  Microtest  plates were purchased  from Falcon  Plastics (Canlab,  To- 
ronto, Ontario, Canada). 
Tumor Cells:  The origin and properties of the highly metastatic DBA/ 
2 strain  tumor called MDAY-D2  has been described in detail (23, 24). The 
WGA  ~  mutant MDW4 was isolated from a mutagenized population of  MDAY- 
D2  cells by  selection  in  growth  medium  containing  WGA  r as  previously 
described (25, 26). MDW4-24a  is a phenotypic  revertant  of MDW4  isolated 
from a metastasis found in DBA/2  mouse which had been injected subcuta- 
neously with MDW4 cells (25). The nonmetastatic  MDW4 cells spontaneously 
hybridize in situ with a bone marrow-derived  host cell thereby regaining the 
"wild type" (i.e., MDAY-D2)  lectin-resistant  and the metastatic  phenotypes 
(26). 
Tumor cells were grown in suspension in RPMI-1640 tissue culture medium 
supplemented  with  10%  fetal calf  serum,  100  U/ml penicillin,  100  /tg/ml 
streptomycin,  and  5  mM ghitamine,  (Grand  Island  Biological Co.,  Grand 
Islands, NY). Tumor cells used for attachment experiments were cultured  3- 
l0 d before the experiment in Iscove's modified Dulbecco's medium (IMDM) 
supplemented with 5 #g/ml human transferrin,  1.5 vM ethanolamine,  100 U/ 
ml penicillin,  100  ~g/ml streptomycin,  and 0.1  mg/ml essentially lipid-free 
BSA which had been detoxified on charcoal. The tumor cells divided at near 
normal rates and could  be passaged in the serum-free medium for extended 
periods of  time (i.e., >  l mo). The cells were tested for myeoplasma by staining 
DNA with 4',6'-diamino-2-phenylidole  and found to be free of  contamination 
during the course of these experiments. 
For lectin  sensitivity  tests,  the  cells at  5  x  108/ml in  fetal calf  serum 
supplemented  medium were plated  in Linbro wells with  concentrations  of 
lectin ranging from 0 to  100 #g/ml.  After 5 d the cells grown in absence of 
lectin had reached maximal density and the cell number in each concentration 
of lectin was determined. 
Glycopeptides:  The total  cellular glycopeptides isolated from ~5  x 
l09 tumor cells of each MDAY-D2  and MDW4 were characterized as docu- 
mented  in reference  20  and  used  in the present  study.  Briefly, lipids were 
removed  by  extraction  with  chloroform/methanol (2:1) (vol/vol)  and  the 
residue was exhaustively digested in  1% (wt/wt) pronase followed by precipi- 
tation  of glycosaminoglycans, DNA, and RNA by the addition  of cetylpyridi- 
nium chloride  to 4 mM. The glycopeptides were desalted on a Bio-Gel P-6 
column then separated on Whatman DE52 cellulose column to obtain neutral 
and sialylated species. Each fraction separated on DE52 cellulose was desalted 
and applied to a concanavalin  A-Sepharose-4B (Con  A/Sepharose)  column. 
The neutral and Con A-bound glycopeptides from WGA  r and WGA' cells were 
shown to be similar  by proton nuclear  magnetic  resonance  analysis. These 
glycopeptides isolated during the study documented  in reference 20 appeared 
by proton nuclear magnetic resonance analysis to be a mixture of-40% Mang, 
15% Mana, 15% Many, 25% Man~, and 15% Mans (structure  5 in Fig. 1) (20). 
Complex glycoproteins are abbreviated  according to the sugar residues at 
the nonreducing  ends, the Manal-6 arm being named first; S denotes  sialic 
acid,  G  is galactose (Gal),  Gn is N-acetylglucosamine  (GIcNAc), and M  is 
Mannose.  There  was essentially no neutral  glycopeptides in MDAY-D2  ex- 
cluded by the Con A/Sepharose column but ~25% of  the MDW4 glycopeptides 
were separated in this way and shown to be triantennary  complex terminating 
in N-acetylglucosamine (GnGnGn, structure  3 in Fig. 1). The sialylated poly- 
N-acetyllactosamine-containing  glycopeptide from MDAY-D2  cells bound to 
DE52 cellulose and was excluded by Con A/sepharose. The structure was also 
present in MDW4 versus host cell hybrid cells removed from the metastasis of 
MDW4-injected  mice (e.g., MDW4-24a).  The presence of a2-3 linked sialic 
acid (SA) and the GIcNAfll-3 Gal linkage were confirmed by proton nuclear 
magnetic resonance analysis (SSS, structure  1 in Fig. 1) (20), 
Glycopeptides from 1 g of conalbumin and 1 g of human tmnsferrin were 
isolated as follows. The glycoprotein was dissolved in 10 ml of 0.1 M "Iris, pH 
7.9,  1 mM CaCI2, 0.01 mM NAN3, 100 mg pronase, and 5 drops of toluene 
blue and incubated  at 37"C for 3 d. After correcting the pH to 7.9 with 1 M 
HCI, 50 mg of pronase was added on days 2 and 3. The sample was applied to 
a Sepharose G25 column (2.5 x  90 cm) and eluted with water. The pronase 
digestion  and desalting  were  repeated.  The  conalbumin glycopeptide  is  a 
bisected triantennary  complex terminating  in GIcNAc as shown in structure 4 
in Fig. I (27). It was retained  by the G25 column and ehited in a symmetric 
peak. The human transferrin  glycopeptide has previously been  shown to be 
mostly sialylated biantennary  SAa2-6GaI~ l-4GlcNAcfll-2Mana 1-6 (SAa2- 
6GalB I--4GIcNAcB  l-2Mana 1-3)Manfl 1--4GtcNAcfl  1-4GIcNAc-Asn (i.e., SS) 
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(28). In our hands, human tmnsferrin oligosaccharides  released from the protein 
by peptide  N-glycosidase and separated  by ion-exchange high-performance 
liquid chromatography revealed 4% neutral, 38% monosialylated, 53% disia- 
lylated, and 5% trisialylated species (data  not shown). The SS glycopeptide 
species was separated on a DEAE Sephacel column (1 x  20 cm) equilibrated 
in 5 mM Tris, pH 7.0, and eluted with a 0-50 mM NaC1 gradient in the same 
buffer. Glycopeptides were quantitated by the hexose assay using mannose as 
the standard (29). Sialic acid was removed from glycopeptides by incubating 
samples in 0.1 M HCI at 80°C for 1 h. 
Dr.  H.  Schachter (Hospital for  Sick Children,  Toronto,  Canada)  kindly 
provided MM (structure 6 in Fig. 1) isolated from human myeloma IgG and 
Mans (structure 7 in Fig. 1) from ovalbumin glycopeptide E. 
Cell Attachment Assay:  Replicate wells in Terasaki Mierotest plates 
were coated with 5 ug essentially fatty acid-free, fraction V BSA and concentra- 
tions of substrate ranging from 0.25 to 250 ng. The BSA and substrates were 
allowed to dry for 3 h followed by the addition of 5 ul of giycopeptide inhibitor'S 
in IMDM. Tumor ceils grown for 3-10 d in IMDM plus supplements were 
washed twice in ice-cold IMDM, adjusted to 105/ml, and 5/~1 was added to 
each well. The plates were maintained at 0*C in a 5% COx atmosphere for 30 
min, then inverted for 30 rain. Cells adhering to the substrate and those falling 
to  the base  of the droplet  were counted and the mean percent  adhering 
calculated from triplicates (8). 
Almond Emulsin Glycosidase Digestion:  Peptide N-glycosidase 
was purified from  10 g of crude almond emulsin fl-glucosidase as previously 
described (30). The enzyme was purified  ~ 1,000-fold and migrated as one 
major band after reduction with 2-mercaptoethanol  on SDS polyacrylamide 
gels. Tumor cells from serum-free medium were washed in IMDM, 0.1 mg/ml 
BSA, and 1.5 U of peptide N-glycosidase  was added to 5-10 x  10  s cells in 1 ml 
of IMDM, 0.1 mg/ml BSA. After 1 h at 37"C, the cells were washed twice in 
cold IMDM and applied to substrate coated microtest plates. 
To monitor the removal of oligosaccharides from the cell surface, sialic acid 
residues were labeled using the NaIO4/Na[3H] BIG method (31). MDW4-24a 
cells at 5 x  10S/ml in PBS were made 2 mM NaIO, and incubated at 0*C for 
20 rain. After washing, 1 mCi of Na[3H] BI-h was added and incubated for a 
further 25  rain at room temperature.  The cells were washed in PBS and 
incubated with peptide N-giycosidase, as described above. After 1 h the cells 
were washed in PBS at 4°C, and the chloroform/methanol  (2:1 vol/vol) insol- 
uble residue was dissolved in 0.25 M NaOH and radioactivity was measured. 
RESULTS 
Tumor Cell Attachment 
In an earlier study, tumor cells were grown in RPMI-1640 
supplemented with fetal calf serum and transferred to serum- 
FIGURE 1  Structures  of  the  Asn-linked  glycopep- 
tides tested as inhibitors of cell attachment in Fig. 3. 
Structure 1 (SSS) is the sialylated  poly-N-acetyllacto- 
samine-containing  glycopeptide  isolated  from 
MDAY-D2 and is also present in the WGA ~ MDW4 
versus host cell hybrid lines removed from a metas- 
tasis of an MDW4-injected mouse (e.g., MDW4-24a). 
Structure 2 is the asialo form of glycopeptide 1 (GGG) 
(20). Structure 3 is the mutant complex glycopeptide 
isolated  from MDW4 cells (GnCnGn). Structure 4 is 
the  conalbumin  glycopeptide  (GnGnGn[Gn]) (27). 
Structure 5 represents  the high-mannose glycopep- 
tide  (Mans_e) isolated  from  both  MDAY-D2  and 
MDW4 cells. Assuming  that only the postulated in- 
termediates of high-mannose processing  were pres- 
ent  (50),  analysis  of  the  proton  nuclear  magnetic 
resonance  spectra  indicated  that  the  sample  con- 
tained  ~40%  Mane,  15%  Mans,  15%  Man7,  25% 
Mane, and  15% Man5. Mans to Man9 are the struc- 
tures resulting from the sequential removal of man- 
nose residues numbered  I-4. Structure 6 is the core 
glycopeptide MM isolated from human myeloma IgG 
(51).  Structure  7  is  Mans  isolated  from  ovalbumin 
(52). R represents  GIcNAcB1-4GIcNAc~'I-Asn. 
free  medium  for  use  in  the  attachment  assay  (8).  Serum 
contains fibronectin as well as other attachment factors that 
may bind to the cells and interfere with the attachment assays. 
Therefore a  serum-free medium  that can support long-term 
growth of the MDAY-D2  cells and MDAY-D2  variants was 
developed.  The  Iscove's-based  serum-free  medium  supple- 
mented with transferrin, ethanolamine, and BSA as described 
in Materials and Methods supported cell growth for months 
in tissue culture at a  rate similar to that of serum-containing 
medium. Tumor  cells grown in serum-free medium attached 
to  laminin,  fibronectin,  and  type  IV  collagen  in  the  same 
manner as cells from serum with one exception. WGA s (i.e., 
MDAY-D2  and  MDW4-24a)  cells  from  serum-containing 
medium attached to laminin (8), but the same cells grown >3 
d in serum-free medium did not attach to laminin. The results 
in Fig. 2 show that for cells grown in serum-free medium, the 
nonmetastatic  WGA r  mutant  (MDW4)  was  more  adhesive 
than  the  WGA s  MDW4-24a  cells  on  fibronectin,  laminin, 
and type IV collagen.  The parental line MDAY-D2  had an 
attachment phenotype identical to that of the MDW4  versus 
host cell hybrid (i.e.,  MDW4-24a)  (8).  Because MDW4  and 
MDW4-24a  were  near  tetraploid  lines and  therefore  larger 
cells than MDAY-D2, they were compared in the experiments 
on inhibition of attachment described here. 
MDW4  has previously been shown to  have three to  four 
times  less  neuraminidase-releasable  cell  surface  sialic  acid 
compared with MDAY-D2  and the MDW4  versus host cell 
hybrid cells and, in addition, the removal of sialic acid from 
WGA s cells with neuraminidase enhanced cell attachment to 
type IV collagen and fibronectin (8). These results led to the 
suggestion that an asialo-glycoconjugate may be involved in 
MDW4  adhesion. A  more detailed examination of the Asn- 
linked oligosaccharide  in mutant  and WGA s cells indicated 
that complex  oligosaccharides in the mutant were also defi- 
cient  in  Gal  and  terminated  in  GlcNac  (Fig.  1)  (20).  The 
mutant was also resistant to the Gal-binding lectin leucoag- 
glutinin (32) and hypersensitive to the GlcNAc-binding lectin 
from  Bandeirea  simpliJqcifolia  seed  (33)  in  agreement  with 
1  4 1  8  THE JOURNAL OF CELL BIOLOGY •  VOLUME 99, 1984 FIGURE  2  Tumor cell attachment (performed 
as described  in  Materials and  Methods) as a 
function of increasing substrate concentration. 
&, attachment of the WGA'  mutant MDW4; 
0, attachment of a WGA S  MDW4  versus host 
cell  hybrid  removed from  a  metastasis of an 
MDW4-injected  mouse (i.e., MDW4-24a)  to 
laminin, fibronectin, and type IV collagen was 
performed  as  described  in  Materials  and 
Methods. 
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the  observed changes  in  oligosaccharide  structure  and  the 
specificities of these lectins (Table I). In an earlier study on 
lectin binding, MDW4 was found to have an increase in cell 
surface Con A-binding sites (34), which probably accounts for 
the increased sensitivity of MDW4 cells to Con A  in tissue 
culture (Table I). 
To  summarize,  the  WGA'  cells  (i.e.,  MDAY-D2  and 
MDW4 versus host cell hybrids) had sialylated poly-N-acetyl- 
lactosamine-containing complex (structure 1 in Fig.  1) which 
has  been  replaced  in  the  mutant  by GlcNAc  terminating 
complex consisting of a mixture of-33% triantennary with 
GIcNAc 2, 4 on the Manal-3 and 66% triantennary with the 
GlcNAc 2, 6 on the Manal-6 (structure 3 in Fig.  1) (20). The 
mutant  also  has  an  apparent  increase  in  Con  A-binding 
oligosaccharides  on  the  cell  surface,  possibly  of the  high 
mannose type (structure 5 in Fig. I). The GlcNAc terminating 
complex isolated  from  the  mutant  as well  as the  Con  A- 
binding high mannose-type glycopeptides appeared to be rea- 
sonable candidates for oligosaccharides that might be involved 
in the increase adhesion of MDW4 cells to substratum. 
GIycopeptide  Inhibition  of MDW4 
Cell Attachment 
In experiments testing the glycopeptide inhibition  of cell 
attachment, microtest wells were coated with a concentration 
of substrate determined on the same day. to give 50-70% cell 
attachment. The glycopeptides were added at a concentration 
of 0.2  nmol/10-~l  well  (i.e.,  20  t,M),  approximately three 
orders of magnitude more than the glycopeptide concentra- 
tion present in the 500 cells added to each well.  The results 
TABLE  I 
Lectin Sensitivity, Metastasis, and Adhesion Characteristics  of 
the Tumor Lines 
Cell line 
Lectin sensitivity (D10)* 
Substra- 
Con  Metas-  turn 
WGA  PHA(1)  BS,  A  tasis*  adhesion  s 
uglml 
MDAY-D2  7  7  >100  33  high  low 
MDW4  >50  >50  6  14  non  high 
MDW4-24a  7  6  >100  40  high  low 
Abbreviations: BS,, Bandeirea simplifolia  lectin  II; PHA(I), leucoagglutinin 
lectin. 
* The  lectin  sensitivities  were  determined  as  described  in  Material  and 
Methods. The concentration of lectin reducing the cell number to 10% of 
the control after 5 d of tissue culture is the D10 value. 
* MDW4  cells  grew at  the  subcutaneous  site  of injection  and  only  the 
progeny of hybrids between MDW4 and a bone marrow-derived host cell 
were found in the metastases (e.g., MDW4-24a). The hybrids had regained 
both the lectin resistance  profile and the high  metastatic  capacity of the 
parental  line MDAY-D2 (23, 26). 
i  MDW4 cells attach more avidly than MDAY-D2 and MDW4-24a to fibro- 
nectin, laminin, and type IV collagen  in vitro. 
in Fig. 3 show that SSS inhibited MDW4 cell attachment to 
laminin but not to fibronectin or type IV collagen. GGG, the 
same glycopeptide with  sialic  acid  removed also  inhibited 
attachment but the mutant glycopeptide GnGnGn showed no 
activity. Glycopeptides with  the  same terminal  residues  as 
those on the inhibitory structures, namely SS and GG from 
human transferrin did not inhibit cell attachment to laminin 
(Fig. 4). A titration of the inhibitors in Fig. 4 showed that the 
concentration of SSS and GGG required for 50% inhibition 
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of MDW4  cells to the  respective substrates  in the  presence and 
absence  of  glycopeptides  was  used  to  calculate  inhibition.  The 
results presented with standard error bars are the mean inhibition 
values of three to six experiments performed in triplicate, the others 
are the mean of two experiments performed in triplicate. 
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FIGURE  4  Inhibition  of  MDW4  cell  attachment  to  laminin  as  a 
function of glycopeptide concentration. Microtest plate wells were 
coated with 15.6 ng of laminin plus 5 p.g of BSA. The glycopeptides 
used were human transferin GG (A); human transferrin SS (@); wild- 
type cellular CGG (O); and wild-type cellular SSS (I-I). Each point is 
the mean of three replicates and error bars represent the standard 
error. 
was  ~1.5  and  0.3  M,  respectively. SSS did  not appear to 
inhibit attachment by binding avidly to laminin as preincu- 
bation  of laminin  on  the  microtest  plates  with  SSS then 
washing did  not  inhibit  MDW4  cell  attachment  (data  not 
shown). 
MM, Mans, and the mixture Mans_9 inhibited MDW4 cell 
attachment to type IV collagen but not to fibronectin (Fig. 
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3). Half-maximal inhibition of cell attachment for MM and 
Man5 was observed at 0.3  and  1 t~M, respectively, and the 
mixture Mans_9 was less active with 50%  inhibition at -10 
~M (Fig.  5). This would be expected if the Man5 component 
of Mans_9 (i.e.,  15%) were the major inhibitor in the mixture. 
None of the complex structures,  1, 2, 3, or 4 shown in Fig.  1 
inhibited MDW4 attachment to type IV collagen (Fig. 3). 
Attachment of Peptide N-Glycosidase- 
treated Cells 
Asn-linked oligosaccharides on the intact cell surface have 
been  shown  to  be  susceptible  to  cleavage  by  peptide  N- 
glycosidase (35).  The  enzyme releases intact  complex and 
high mannose oligosaccharides from the protein leaving the 
~-amino of the Asn on the reducing end. Both MDW4 and 
MDW4-24a cells were treated with peptide N-glycosidase and 
compared to  mock-treated cells for attachment to type IV 
collagen and laminin (Fig.  6).  Enzyme-treated MDW4 cells 
were less adhesive on type IV collagen as would be expected 
if the mechanism of type IV collagen binding required the 
recognition  of cell  surface high  mannose structures.  There 
appears to be less high Man structures on the WGA  s cells (34) 
and this may account for their nonadhesive behavior on type 
IV collagen (Fig. 2). As would be predicted from this line of 
reasoning, MDW4-24a attachment to type IV collagen was 
not affected by peptide N-glycosidase treatment. 
Although treatment of MDW4 cells inhibited attachment 
to type  IV collagen,  no effect was seen  for attachment to 
laminin suggesting that Asn-linked oligosaccharides were not 
mediating cell attachment to laminin.  MDW4-24a cells be- 
came more adhesive to laminin after peptide N-glycosidase 
treatment (Fig. 6). This result is consistent with the idea that 
WGA  s cells can attach to laminin provided that an inhibiting 
Asn-linked oligosaccharide is removed, presumably the SSS 
structure. The enzyme treatment did not restore the attach- 
ment phenotype of MDW4-24a on laminin to that of MDW4 
possibly due to the incomplete removal of SSS from the cell 
surface (Fig.  6,  inset).  The  removal of the  oligosaccharide 
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as a function of glycopeptide concentration. Microtest plate wells 
were coated with 4  ng of type IV collagen plus 5 #g of BSA. The 
glycopeptides  were  conalbumin,  GnGnGn(Gn)  (17); MDW4,  Gn- 
GnGn (11); Man5_9 (@); ovalbumin Man5 (A); and IgG, MM (0). I00 
8O 
60 
40 
<I 
20 
/ 
o 7a  is.s  aa.t  ~.5  =2s 
Laminin (ng) 
,o0  
• 
5o0t  5 
Units/106cells  ~  /+  ® 
o.s  Lo  2.o  3.9  r.a  i~s  at.~  ~..~  12s  ~5o 
Collagen  ( ng ) 
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from native glycoproteins by peptide N-glycosidase has been 
shown to vary depending on tertiary structure and accessibility 
of the oligosaccharides (30). 
DISCUSSION 
Attachment studies using lectin-resistant mutants with lesions 
in oligosaccharide synthesis (8, 10) and the use of  the inhibitor 
tunicamycin (12,  13)  have provided indirect evidence that 
Asn-linked oligosaccharide are required for various types of 
cell adhesion phenomenon. In this report, Asn-linked glyco- 
peptides isolated from a WGA  r mutant adhesive on fibronec- 
tin, laminin, and type IV collagen, and from the nonattaching 
wild-type cells  were  tested  for their  ability  to  inhibit  cell 
attachment. 
MDW4 cell attachment to type IV collagen was inhibited 
by the  mannose terminating glycopeptides MM and  Man5 
and to a  lesser degree by the mixture Mans_9. MDW4 cells 
have more cell surface Con A-binding sites than the WGA  s 
cells (34).  Because the major Con  A-binding glycopeptides 
isolated from these cells were the high  mannose structures 
(20),  it is possible that inhibition  of MDW4 attachment to 
type IV collagen by the Man terminating glycopeptides was 
due to competition with similar structures on the cell surface 
for an oligosaccharide-binding site in the collagen. Removal 
of Asn-linked oligosaccharides by almund emulsin peptide N- 
glycosidase treatment reduced MDW4 attachment to type IV 
collagen supporting the hypothesis that Asn-linked oligosac- 
charides (e.g., Mans) may directly mediate cell attachment to 
type IV collagen. Man6_9 species are usually found inside the 
cell as processing intermediates in the production of complex, 
Mans, and hybrid structures (36). Therefore, the finding that 
Man5  glycopeptide was  a  more  potent  inhibitor  than  the 
mixture Mans_9 may be due to a preference of  type IV collagen 
for the processed high mannose structure. A lectin activity on 
teratocarcinoma cells recognizing high mannose oligosaccha- 
rides has been reported to mediate homotypic cell adhesion 
(37). Because laminin and type IV collagen have been isolated 
from teratocarcinoma ECM (38),  it is possible that the car- 
bohydrate binding component detected in this study was type 
IV collagen. 
In that the major change in Asn-linked oligosaccharides in 
the mutant cells was the acquisition of GnGnGn (20),  it was 
suspected that this  structure  may be important for the  in- 
creased adhesion of the cells to one or more ECM proteins. 
However, the mutant GnGnGn structure did not inhibit at- 
tachment to laminin, fibronectin, or type IV collagen at the 
concentrations tested. This does not eliminate the possibility 
that  the  presence of GnGnGn  or absence of the  wild-type 
structure affects the expression or activity of a glycoprotein 
involved in  cell  attachment.  Rather than the presence of a 
new mutant oligosaccharide, the absence of the wild type SSS 
appeared to be the cause of increased MDW4 attachment to 
laminin. SSS is absent from MDW4 cells yet its addition to 
the  attachment assay inhibited  MDW4  cell  attachment to 
laminin,  possibly due  to  steric interference  at the  laminin 
receptor-laminin binding site. Laminin receptors on MDW4- 
24a cells may be glycosylated with the SSS structure conse- 
quently blocking laminin binding or the proximity of SSS on 
other cell surface glycoproteins may be sufficient to block cell 
attachment to laminin.  MDW4-24a  cells showed increased 
attachment to laminin after they had been treated with peptide 
N-glycosidase presumably due to the partial removal of SSS 
from the cell surface. 
A  number of other structurally related glycopeptides did 
not  inhibit  cell  attachment  to  laminin.  SS,  GG,  and  the 
triantennary  GnGnGn  were  not  inhibitory,  indicating  that 
recognition of SSS and GGG required more of the structure 
than terminal monosaccharides, and that triantennary substi- 
tution of the core was also insufficient. It is possible that the 
repeating Gal/~ 1-4GlcNAc in the antenna of SSS was func- 
tionally important for inhibiting cell attachment to laminin. 
Mobile cells encountering laminin in vascular ECM such as 
erythrocytes (39)  and  the  K562  leukemia  (40)  have  been 
shown to have the large Asn-linked poly-N-acetyllactosamine- 
containing glycopeptide. In addition,  embryonal carcinoma 
cells appear to have a similar structure that disappears during 
in vitro differentiation (41).  Because laminin appears at an 
early stage in embryogenesis (42), the presence of the poly-N- 
acetyllactosamine-containing  oligosaccharide  could  play  a 
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MDW4 cell attachment to fibronectin was not inhibited by 
the Asn-linked glycopeptides used in this study. It has been 
suggested that ganglioside GTIb mediates cell attachment to 
fibronectin (43); however, GTIb also inhibited cell attachment 
to  gelatin  and  lectins  indicating  a  lack of specificity  (18). 
Lesions in the glucosaminoglycans, glycolipids, and O-linked 
oligosaccharides of MDW4 are being investigated as possible 
candidates for the increased adhesion of MDW4 to fibronec- 
tin. 
The cellular environment can have a profound effect both 
qualitatively and quantitatively on the cell surface oligosac- 
charide structures. Confluent cells compared with cells in log- 
phase growth have increased high mannose to complex ratios 
(44).  A  recent  study  comparing  tumor  cells  growing  at  a 
subcutaneous site with tumor cells in the liver demonstrated 
changes  in  the  WGA-binding  glycoproteins of the  plasma 
membrane due  apparently to the tissue environment since 
transplanting the tumor cells from the subcutaneous site to 
liver or the reverse was accompanied by a rapid reverse in the 
glycoprotein pattern (45). Therefore, differences in tissue en- 
vironments  which  influence  cell  surface  oligosaccharides 
expression may allow metastatic tumor cells to be relatively 
nonadherent to  ECM  proteins  at  the  primary  and,  subse- 
quently, attach at the secondary site to similar ECM proteins. 
Modulation of adhesion by altering oligosaccharide structure 
has been observed in embryonic tissue. Removal of sialic acid 
from oligosaccharides on retinal cell-cell adhesion molecules 
accompanies development  from embryonic to adult  forms 
and from inactive to active homotypic binding (45). 
Yogeeswaran and Salk (9) have shown that the metastatic 
capacity of a  range of murine tumor cell lines is positively 
correlated with the degree of sialylation of available galactose 
and N-acetylgalactosamine residues on the cell surface glyco- 
conjugates.  These  results  suggest  that  the  more  completed 
(i.e., sialylated) the complex oligosaccharides, the more met- 
astatic and autonomous from host growth controls the tumor 
cell becomes. A  number of under-sialylated WGA  r mutants 
isolated from the BI6 melanoma (47),  RAW-117-H10  lym- 
phosarcoma (48) and MDAY-D2 (25) have been found to be 
less  metastatic  than  the  respective  parental  cell  line.  For 
example, MDW4 has been shown to be more susceptible to 
natural killer cells, although the mutant has not acquired new 
tumor antigens (49), and is more adhesive to laminin, fibro- 
nectin, and type IV collagen.  Both natural killer sensitivity 
and cell adhesion appear to be related to the expression of 
incomplete complex oligosaccharides in the mutant (Dennis, 
J. W., manuscript submitted for publication). Therefore, it is 
tempting to  speculate that the completion  of the  complex 
oligosaccharide masks or suppresses recognition of underlying 
oligosaccharide structures and consequently liberates the met- 
astatic tumor cell from certain growth-controlling factors such 
as cell adhesion, to ECM protein and natural killer cell lysis. 
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